Active Ingredient(s): Plerixafor
FDA Approved: * December 15, 2008
Pharm Company: * GENZYME
Category: Cancer

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. The stem cells are then extracted from the blood and transplanted back to the patient. The drug was developed by AnorMED, which was subsequently bought by Genzyme. Contents 1 Medical uses 2 Contraindications 2.1 Pregnancy and lactation 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 6 Chemist... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Mozobil 24 mg/1.2ml Subcutaneous Solution
NDC: 0024-5862
Sanofi-aventis U.S. LLC
Mozobil 24 mg/1.2ml Subcutaneous Solution
NDC: 58468-0140
Genzyme Corporation

Popular Topics

Stem Cell stimulation, Mozobil

I would like to find a doctor who will prescribe this to me for stem cell inhancement for an upcoming dental surgery. Wo...